Figure 3.

Kaplan-Meier estimates of progression free survival and 5-year overall survival in patients with Ta and T1 tumours. Kaplan-Meier analysis of progression free survival in strata according to (a) negative, intermediate and high RBM3 expression and (b) negative-intermediate versus high expression, and 5-year overall survival in (c) negative, intermediate and high RBM3 expression and (d) negative versus positive expression.

Boman et al. BMC Urology 2013 13:17   doi:10.1186/1471-2490-13-17
Download authors' original image